MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析

◆英語タイトル:MEI Pharma Inc (MEIP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61270FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MEI Pharma Inc (MEIP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MEI Pharma Inc (MEI Pharma), formerly Marshall Edwards Inc, develops drugs for the treatment of cancer. The company’s drug candidates include pracinostat, an oral histone deacetylase inhibitor, intended for the treatment of advanced hematological diseases including myelodysplastic syndrome; ME-344, a mitochondrial inhibitor intended for the treatment of HER2-negative breast cancer and solid tumors; and Zandelisib (ME-401), an oral PI3K delta inhibitor for relapsed or refractory B-cell malignancies. The company also develops and commercializes Voruciclib, an oral and selective cyclin-dependent kinase (CDK) inhibitor intented for the treatment of acute myeloid leukemia (AML) and B-cell malignancies through an agreement with Presage. MEI Pharma is headquartered in San Diego, California, the US.

MEI Pharma Inc Key Recent Developments

Apr 05,2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04,2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10,2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09,2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07,2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MEI Pharma Inc – Key Facts
MEI Pharma Inc – Key Employees
MEI Pharma Inc – Key Employee Biographies
MEI Pharma Inc – Major Products and Services
MEI Pharma Inc – History
MEI Pharma Inc – Company Statement
MEI Pharma Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
MEI Pharma Inc – Business Description
R&D Overview
MEI Pharma Inc – Corporate Strategy
MEI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
MEI Pharma Inc – Strengths
MEI Pharma Inc – Weaknesses
MEI Pharma Inc – Opportunities
MEI Pharma Inc – Threats
MEI Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 05, 2021: MEI Pharma to present at the 20th Annual Needham Virtual Healthcare Conference
Feb 04, 2021: MEI Pharma Reports Second Quarter Fiscal Year 2021 Results and Operational Highlights
Nov 10, 2020: MEI Pharma reports first quarter fiscal year 2021 results and operational highlights
Sep 09, 2020: MEI Pharma reports fiscal year 2020 results and operational highlights
May 07, 2020: MEI Pharma reports fiscal third-quarter 2020 results and recent corporate highlights
Apr 14, 2020: MEI Pharma appoints Cheryl Cohen, product launch and commercialization veteran, to its board of directors
Feb 06, 2020: MEI Pharma reports fiscal second-quarter 2020 results and operational highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
MEI Pharma Inc, Key Facts
MEI Pharma Inc, Key Employees
MEI Pharma Inc, Key Employee Biographies
MEI Pharma Inc, Major Products and Services
MEI Pharma Inc, History
MEI Pharma Inc, Key Competitors
MEI Pharma Inc, Ratios based on current share price
MEI Pharma Inc, Annual Ratios
MEI Pharma Inc, Annual Ratios (Cont...1)
MEI Pharma Inc, Interim Ratios
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
MEI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
MEI Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MEI Pharma Inc (MEIP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Baytex Energy Corp (BTE):企業の財務・戦略的SWOT分析
    Baytex Energy Corp (BTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cadence Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. Its product allows users to regain the ability and endurance to stand, walk and return …
  • Bang & Olufsen AS:企業の戦略・SWOT・財務情報
    Bang & Olufsen AS - Strategy, SWOT and Corporate Finance Report Summary Bang & Olufsen AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Presbia Plc (LENS):医療機器:M&Aディール及び事業提携情報
    Summary Presbia Plc (Presbia) is a medical device company. The company develops presbyopia-correcting presbia flexivue microlens, a solutions for the age-related loss of the ability to read or focus on near objects. Its microlens helps people to read newspapers, restaurant menus, cell phone messages …
  • NII Holdings, Inc.:企業の戦略・SWOT・財務情報
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • U.S. National Geospatial-Intelligence Agency:企業の戦略的SWOT分析
    U.S. National Geospatial-Intelligence Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an industrial equipment company that manufactures and markets engineered precision bearings and products. The company offers products through industrial and aerospace division. Its industrial products include ball bearings, cam followers, collets and toolho …
  • CLAAS KGaA mbH:企業の戦略的SWOT分析
    CLAAS KGaA mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Hafslund AS:企業の戦略・SWOT・財務情報
    Hafslund AS - Strategy, SWOT and Corporate Finance Report Summary Hafslund AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Slater and Gordon Limited:企業の戦略・SWOT・財務情報
    Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report Summary Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Deltex Medical Group Plc (DEMG):企業の財務・戦略的SWOT分析
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • Zimmer Biomet Holdings Inc.:企業のM&A・事業提携・投資動向
    Zimmer Biomet Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zimmer Biomet Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Kraftwerke Oberhasli AG:企業の戦略的SWOT分析
    Kraftwerke Oberhasli AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Knoll Inc (KNL):企業の財務・戦略的SWOT分析
    Knoll Inc (KNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ferguson Enterprises LLC:企業の戦略的SWOT分析
    Ferguson Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Phoenix Brands LLC:企業の戦略・SWOT・財務情報
    Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report Summary Phoenix Brands LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆